Factors Affecting Mortality in Hematology Patients Accepted to the Intensive Care Unit

Creative Commons License

TALAN L., ALTINTAŞ N. D.

ERCIYES MEDICAL JOURNAL, cilt.43, sa.2, ss.152-155, 2021 (ESCI) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 43 Sayı: 2
  • Basım Tarihi: 2021
  • Doi Numarası: 10.14744/etd.2020.14477
  • Dergi Adı: ERCIYES MEDICAL JOURNAL
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Academic Search Premier, CAB Abstracts, EMBASE, Veterinary Science Database, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.152-155
  • Anahtar Kelimeler: ICU, hematology, respiratory failure, CRITICALLY-ILL PATIENTS, OUTCOMES, MALIGNANCIES
  • Ankara Üniversitesi Adresli: Evet

Özet

Objective: Patients with hematologic diseases can have increased life expectancy with newly developed chemotherapeutic agents, hematopoietic stem-cell transplantation, and further supportive therapy. However, intensive therapies lead to more life-threatening complications that require intensive care unit (ICU) admission. Therefore, understanding the factors affecting mortality is important when accepting these patients to the ICU. This study was conducted to explore the factors affecting the mortality of patients admitted to medical ICUs with a diagnosis of hematologic disease.